TipRanks
Veeva Systems (CH:VEE)
:VEE
Switzerland Market

Veeva Systems (VEE) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

VEE Analyst Ratings

Moderate Buy
24Ratings
Moderate Buy
17 Buy
6 Hold
1 Sell
Based on 24 analysts giving stock ratings to
Veeva
Systems
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

VEE Stock 12 Month Forecast

Average Price Target

CHF242.29
▲(5.33% Upside)
Based on 24 Wall Street analysts offering 12 month price targets for Veeva Systems in the last 3 months. The average price target is CHF242.29 with a high forecast of CHF280.61 and a low forecast of CHF148.56. The average price target represents a 5.33% change from the last price of CHF230.03.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"123":"CHF123","202":"CHF202","281":"CHF281","162.5":"CHF162.5","241.5":"CHF241.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":280.6070014,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF280.61</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":242.2888184357143,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF242.29</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":148.5566478,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF148.56</span>\n  </div></div>","useHTML":true}}],"tickPositions":[123,162.5,202,241.5,281],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,230.032,233.92238472307693,237.81276944615385,241.70315416923077,245.5935388923077,249.4839236153846,253.37430833846156,257.2646930615385,261.1550777846154,265.0454625076923,268.93584723076924,272.82623195384616,276.7166166769231,{"y":280.6070014,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,230.032,230.97483218736264,231.9176643747253,232.86049656208792,233.80332874945057,234.7461609368132,235.68899312417582,236.63182531153848,237.5746574989011,238.51748968626373,239.46032187362638,240.403154060989,241.34598624835166,{"y":242.2888184357143,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,230.032,223.76466521538464,217.49733043076924,211.22999564615387,204.96266086153847,198.6953260769231,192.4279912923077,186.16065650769232,179.89332172307692,173.62598693846155,167.35865215384615,161.09131736923078,154.8239825846154,{"y":148.5566478,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":124.8,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":230.032,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF280.61Average Price TargetCHF242.29Lowest Price TargetCHF148.56
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on CH:VEE
Wells Fargo
Wells Fargo
CHF272.35
Buy
18.40%
Upside
Reiterated
09/23/26
Analysts Offer Insights on Healthcare Companies: Royalty Pharma (NASDAQ: RPRX), Travere Therapeutics (NASDAQ: TVTX) and Veeva Systems (NYSE: VEEV)
Morgan Stanley Analyst forecast on CH:VEE
Morgan Stanley
Morgan Stanley
CHF226.96
Hold
-1.33%
Downside
Assigned
09/18/26
Veeva Systems (VEEV) Gets a Hold from Morgan Stanley
CFRA Analyst forecast on CH:VEE
Unknown Analyst
CFRA
Not Ranked
CFRA
―
Buy
―
Upgraded
09/16/26
CFRA upgrades Veeva Systems (VEEV) to a Buy
TD Cowen
CHF233.56
Buy
1.54%
Upside
Reiterated
09/15/26
Analysts Conflicted on These Healthcare Names: Veeva Systems (NYSE: VEEV), Mereo Biopharma Group Plc (NASDAQ: MREO) and Tvardi Therapeutics (NASDAQ: TVRD)
J.P. Morgan Analyst forecast on CH:VEE
J.P. Morgan
J.P. Morgan
CHF246.77
Buy
7.28%
Upside
Reiterated
09/01/26
Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and Kodiak Sciences (NASDAQ: KOD)
UBS
CHF156.81→CHF239.34
Hold
4.05%
Upside
Assigned
08/28/26
Veeva price target raised to $290 from $190 at UBSVeeva price target raised to $290 from $190 at UBS
Citi
CHF156.81→CHF225.31
Hold
-2.05%
Downside
Reiterated
08/28/26
Veeva price target raised to $273 from $190 at CitiVeeva price target raised to $273 from $190 at Citi
Barclays Analyst forecast on CH:VEE
Barclays
Barclays
CHF226.96→CHF259.97
Buy
13.02%
Upside
Reiterated
08/27/26
Barclays Keeps Their Buy Rating on Veeva Systems (VEEV)
Robert W. Baird Analyst forecast on CH:VEE
Robert W. Baird
Robert W. Baird
CHF214.58→CHF247.59
Buy
7.64%
Upside
Reiterated
08/27/26
Veeva price target raised to $300 from $260 at BairdVeeva price target raised to $300 from $260 at Baird
Evercore ISI Analyst forecast on CH:VEE
Evercore ISI
Evercore ISI
CHF152.68→CHF206.33
Hold
-10.30%
Downside
Reiterated
08/27/26
Veeva price target raised to $250 from $185 at Evercore ISIVeeva price target raised to $250 from $185 at Evercore ISI
Oppenheimer Analyst forecast on CH:VEE
Oppenheimer
Oppenheimer
CHF247.59→CHF268.23
Buy
16.61%
Upside
Reiterated
08/27/26
Oppenheimer Keeps Their Buy Rating on Veeva Systems (VEEV)
Raymond James Analyst forecast on CH:VEE
Raymond James
Raymond James
CHF185.7→CHF272.35
Buy
18.40%
Upside
Reiterated
08/27/26
Veeva price target raised to $330 from $225 at Raymond JamesVeeva price target raised to $330 from $225 at Raymond James
Stifel Nicolaus Analyst forecast on CH:VEE
Stifel Nicolaus
Stifel Nicolaus
CHF226.96→CHF247.59
Buy
7.64%
Upside
Reiterated
08/27/26
Veeva Systems (VEEV) Receives a Buy from Stifel Nicolaus
Piper Sandler Analyst forecast on CH:VEE
Piper Sandler
Piper Sandler
CHF243.47→CHF264.1
Buy
14.81%
Upside
Reiterated
08/27/26
Veeva price target raised to $320 from $295 at Piper SandlerVeeva price target raised to $320 from $295 at Piper Sandler
William Blair Analyst forecast on CH:VEE
William Blair
William Blair
―
Buy
―
Reiterated
08/27/26
Veeva Gets Buy Rating as Revenue Reaccelerates, Guidance Rises and AI-Driven Life Sciences Moat Widens
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on CH:VEE
Wells Fargo
Wells Fargo
CHF272.35
Buy
18.40%
Upside
Reiterated
09/23/26
Analysts Offer Insights on Healthcare Companies: Royalty Pharma (NASDAQ: RPRX), Travere Therapeutics (NASDAQ: TVTX) and Veeva Systems (NYSE: VEEV)
Morgan Stanley Analyst forecast on CH:VEE
Morgan Stanley
Morgan Stanley
CHF226.96
Hold
-1.33%
Downside
Assigned
09/18/26
Veeva Systems (VEEV) Gets a Hold from Morgan Stanley
CFRA Analyst forecast on CH:VEE
Unknown Analyst
CFRA
Not Ranked
CFRA
―
Buy
―
Upgraded
09/16/26
CFRA upgrades Veeva Systems (VEEV) to a Buy
TD Cowen
CHF233.56
Buy
1.54%
Upside
Reiterated
09/15/26
Analysts Conflicted on These Healthcare Names: Veeva Systems (NYSE: VEEV), Mereo Biopharma Group Plc (NASDAQ: MREO) and Tvardi Therapeutics (NASDAQ: TVRD)
J.P. Morgan Analyst forecast on CH:VEE
J.P. Morgan
J.P. Morgan
CHF246.77
Buy
7.28%
Upside
Reiterated
09/01/26
Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and Kodiak Sciences (NASDAQ: KOD)
UBS
CHF156.81→CHF239.34
Hold
4.05%
Upside
Assigned
08/28/26
Veeva price target raised to $290 from $190 at UBSVeeva price target raised to $290 from $190 at UBS
Citi
CHF156.81→CHF225.31
Hold
-2.05%
Downside
Reiterated
08/28/26
Veeva price target raised to $273 from $190 at CitiVeeva price target raised to $273 from $190 at Citi
Barclays Analyst forecast on CH:VEE
Barclays
Barclays
CHF226.96→CHF259.97
Buy
13.02%
Upside
Reiterated
08/27/26
Barclays Keeps Their Buy Rating on Veeva Systems (VEEV)
Robert W. Baird Analyst forecast on CH:VEE
Robert W. Baird
Robert W. Baird
CHF214.58→CHF247.59
Buy
7.64%
Upside
Reiterated
08/27/26
Veeva price target raised to $300 from $260 at BairdVeeva price target raised to $300 from $260 at Baird
Evercore ISI Analyst forecast on CH:VEE
Evercore ISI
Evercore ISI
CHF152.68→CHF206.33
Hold
-10.30%
Downside
Reiterated
08/27/26
Veeva price target raised to $250 from $185 at Evercore ISIVeeva price target raised to $250 from $185 at Evercore ISI
Oppenheimer Analyst forecast on CH:VEE
Oppenheimer
Oppenheimer
CHF247.59→CHF268.23
Buy
16.61%
Upside
Reiterated
08/27/26
Oppenheimer Keeps Their Buy Rating on Veeva Systems (VEEV)
Raymond James Analyst forecast on CH:VEE
Raymond James
Raymond James
CHF185.7→CHF272.35
Buy
18.40%
Upside
Reiterated
08/27/26
Veeva price target raised to $330 from $225 at Raymond JamesVeeva price target raised to $330 from $225 at Raymond James
Stifel Nicolaus Analyst forecast on CH:VEE
Stifel Nicolaus
Stifel Nicolaus
CHF226.96→CHF247.59
Buy
7.64%
Upside
Reiterated
08/27/26
Veeva Systems (VEEV) Receives a Buy from Stifel Nicolaus
Piper Sandler Analyst forecast on CH:VEE
Piper Sandler
Piper Sandler
CHF243.47→CHF264.1
Buy
14.81%
Upside
Reiterated
08/27/26
Veeva price target raised to $320 from $295 at Piper SandlerVeeva price target raised to $320 from $295 at Piper Sandler
William Blair Analyst forecast on CH:VEE
William Blair
William Blair
―
Buy
―
Reiterated
08/27/26
Veeva Gets Buy Rating as Revenue Reaccelerates, Guidance Rises and AI-Driven Life Sciences Moat Widens
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ESTAEstablishment Labs Holdings
LGNDLigand Pharma
HROWHarrow Health
STOKStoke Therapeutics
AXGNAxoGen
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Veeva Systems

3 Months
Stan BerenshteynWells Fargo
Success Rate
17/25 ratings generated profit
68%
Average Return
+9.10%
Copying Stan Berenshteyn's trades and holding each position for 3 Months would result in 68.00% of your transactions generating a profit, with an average return of +9.10% per trade.
1 Year
Kenneth WongOppenheimer
Success Rate
34/49 ratings generated profit
69%
Average Return
+19.57%
Copying Kenneth Wong's trades and holding each position for 1 Year would result in 69.39% of your transactions generating a profit, with an average return of +19.57% per trade.
2 Years
Rishi JaluriaRBC Capital
Success Rate
18/24 ratings generated profit
75%
Average Return
+22.08%
Copying Rishi Jaluria's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +22.08% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VEE Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
11
10
11
9
2
Buy
13
13
15
39
34
Hold
7
8
7
13
7
Sell
1
1
1
2
1
Strong Sell
0
0
0
0
0
total
32
32
34
63
44
In the current month, VEE has received 36 Buy Ratings, 7 Hold Ratings, and 1 Sell Ratings. VEE average Analyst price target in the past 3 months is 242.29.
Each month's total comprises the sum of three months' worth of ratings.

VEE Financial Forecast

VEE Earnings Forecast

Next quarter’s earnings estimate for VEE is CHF1.95 with a range of CHF1.93 to CHF2.00. The previous quarter’s EPS was CHF1.96. VEE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year VEE has Performed in-line its overall industry.
Next quarter’s earnings estimate for VEE is CHF1.95 with a range of CHF1.93 to CHF2.00. The previous quarter’s EPS was CHF1.96. VEE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year VEE has Performed in-line its overall industry.

VEE Sales Forecast

Next quarter’s sales forecast for VEE is CHF779.80M with a range of CHF777.62M to CHF788.21M. The previous quarter’s sales results were CHF773.93M. VEE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year VEE has Performed in-line its overall industry.
Next quarter’s sales forecast for VEE is CHF779.80M with a range of CHF777.62M to CHF788.21M. The previous quarter’s sales results were CHF773.93M. VEE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year VEE has Performed in-line its overall industry.

VEE Stock Forecast FAQ

What is CH:VEE’s average 12-month price target, according to analysts?
Based on analyst ratings, Veeva Systems’s 12-month average price target is 242.29.
    What is CH:VEE’s upside potential, based on the analysts’ average price target?
    Veeva Systems has 5.33% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Veeva Systems a Buy, Sell or Hold?
          Veeva Systems has a consensus rating of Moderate Buy, which is based on 17 buy ratings, 6 hold ratings and 1 sell ratings.
            What is Veeva Systems’s share price target?
            The average share price target for Veeva Systems is 242.29. This is based on 24 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF280.61 ,and the lowest forecast is CHF148.56. The average share price target represents 5.33% Increase from the current price of CHF230.03.
              What do analysts say about Veeva Systems?
              Veeva Systems’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 24 Wall Streets Analysts.
                How can I buy shares of Veeva Systems?
                To buy shares of CH:VEE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.